Acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine
C22H30ClN5O4 — CID 144958806
Data last refreshed: (MolForge compound catalog, from PubChem)
About Acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine
Acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine (PubChem CID 144958806) has the molecular formula C22H30ClN5O4 and a molecular weight of 463.97 g/mol. Its IUPAC name is acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine.
Molecular Properties
| Compound Name | Acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine |
|---|---|
| PubChem CID | 144958806 |
| Molecular Formula | C22H30ClN5O4 |
| Molecular Weight | 463.97 g/mol |
| Exact Mass | 463.20 |
| IUPAC Name | acetic acid;2-[(4R)-1-(5-chloro-2-methoxy-4-pyridinyl)-3-methylpiperidin-4-yl]oxy-5-pyrrolidin-1-ylpyrazine |
| SMILES | CC(=O)O.COc1cc(N2CC[C@@H](Oc3cnc(N4CCCC4)cn3)C(C)C2)c(Cl)cn1 |
| InChI | InChI=1S/C20H26ClN5O2.C2H4O2/c1-14-13-26(16-9-19(27-2)23-10-15(16)21)8-5-17(14)28-20-12-22-18(11-24-20)25-6-3-4-7-25;1-2(3)4/h9-12,14,17H,3-8,13H2,1-2H3;1H3,(H,3,4)/t14?,17-;/m1./s1 |
| InChIKey | IEJDORNHFYDDKM-JZABEEBUSA-N |
| XLogP | 3.52 |
| TPSA | 100.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.97 |
| LogP ≤ 5 | 3.52 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144958806 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.